Valeant Pharmaceuticals (VRX) Announces Resignation of CFO, Names Peter J. Blott as Replacement

March 21, 2007 8:39 AM EDT Send to a Friend
Valeant Pharmaceuticals (NYSE: VRX) announced the resignation of its chief financial officer, Bary G ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login